SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
180 hedge funds and large institutions have $2.77B invested in SpringWorks Therapeutics in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 78 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
75% more capital invested
Capital invested by funds: $1.58B → $2.77B (+$1.19B)
22% more funds holding
Funds holding: 147 → 180 (+33)
4.05% less ownership
Funds ownership: 109.42% → 105.37% (-4%)
Holders
180
Holding in Top 10
9
Calls
$29.4M
Puts
$6.84M
Top Buyers
| 1 | +$81.6M | |
| 2 | +$63.4M | |
| 3 | +$59.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$52M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$44.6M |
Top Sellers
| 1 | -$80M | |
| 2 | -$71.2M | |
| 3 | -$69.4M | |
| 4 |
O
OrbiMed
New York
|
-$27.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$14.5M |